To download the complete article, visit: http://bit.ly/2ncVkXM
2016 was a landmark year for India as demonetisation nudged the country towards an inclusive, less-cash dependant, digital future. In 2017, the government should push for the increased adoption of technology to transform the country’s public healthcare system and ensure a healthy future for all Indians. The low priority accorded to healthcare in India over … Continue reading eHealth Push Can Build a ‘Swastha Bharat’ in 2017
2016 was a landmark year for the biotechnology industry as it was for the first time that the revolutionary CRISPR-Cas9 gene-editing technique was used in humans. With more human trials involving CRISPR-Cas9 scheduled to be conducted, I believe 2017 will be the year when the technology’s potential to treat human diseases could receive strong clinical … Continue reading CRISPR: A Game Changing Technology for a More Equitable Future
Over the past month, I have been a silent spectator, witnessing a miserable drama unfold in Bangalore. This is regarding a remarkable project to safeguard an important art collection through the upkeep and modernisation of an ailing state gallery the Venkatappa Art Gallery (VAG), by turning it into a new museum for the city. These plans … Continue reading What Price Philanthropy?
When you can’t tax the rich, tax the less well-off. This is exactly what the Karnataka government did by notifying all hospitals to collect 8% luxury tax from every patient in an intensive care unit (ICU). Lying on an ICU bed fighting for one’s life is not a luxury by any stretch. But the room … Continue reading Can healthcare costs in India come down further?
Finance Minister Arun Jaitley has a challenging task at hand to present a Budget for FY17 that spurs India’s growth at a time when the economic scenario appears challenging, both externally and internally. The global economy is expected to slow down further in 2016 pulled down by weakness in major emerging economies like China, Brazil … Continue reading Pharma & Biotech Sector Must Get Its Due This Budget
These are exciting times for the Life Sciences sector as it builds on its understanding of the disease at the cellular and genetic level to usher in new and differentiated therapies into the market. Furthermore, biomedical advances are likely to transform global health with early diagnosis and therapeutic intervention for chronic and killer diseases like … Continue reading The Top 5 Life Sciences Developments You Should Look Out for in 2016
In today’s world, technology is playing a transformational role in enabling innovation and driving change. New ideas, new business models and new technologies are leading to the birth of the “ideas economy,” where the “innovation quotient” has emerged as the key determinant of market value. India will lose out on the opportunity to benefit from innovation-led, … Continue reading IP Creation Can Make India the Next Global Innovation Hub
My Speech at The Chemical Heritage Foundation (CHF) I am deeply grateful to the Chemical Heritage Foundation for awarding me the 2014 Othmer Gold Prize. This is an honour akin to being invited to join an extraordinary league of scientists, engineers, entrepreneurs, thought leaders and philanthropists, an emotion that is both proud and humbling at … Continue reading The Global Right to Healthcare
By Kiran Mazumdar Shaw The hefty fine that Ranbaxy Laboratories will pay as part of the drug safety settlement in the US threatens to seriously erode its reputation that can take years to regain. This is particularly sad as Ranbaxy has been a leader and stalwart among Indian generic drug makers that have, over the … Continue reading Indian pharma companies need to be surefooted in their approach to quality